»ó´Ü¿©¹é
±â»ç (Àüü 520°Ç)
[Sub Story] ÆæÅ͹Î/ÅäÇǶó¸ÞÀÌÆ® ER Àå±â°£ ¶Ù¾î³­ üÁß °¨¼ÒÈ¿°ú º¸°í ÀÓ¼¼Çü ±âÀÚ 2020-05-13 16:55
[Journal Briefing] ¾ß°£ °íÇ÷¾Ð ȯÀÚ, ÀÎÁö±â´É ÀúÇÏ ÁÖÀÇ ÇãÈñÀ± ±âÀÚ 2020-04-29 14:20
[Expert Opinion] ´ç´¢º´¼º ½ÅÀ庴ÁõÀÇ °ü¸®: »õ·Î¿î ¾àÁ¦¸¦ Áß½ÉÀ¸·Î THE MOST 2020-04-29 11:45
[Journal Briefing] º¨ÆäµµÀͻꡤ°æ±¸¿ë ¼¼¸¶±Û·çŸÀ̵å À¯·´ ½ÂÀΠ'û½ÅÈ£' ÇãÈñÀ± ±âÀÚ 2020-03-13 10:09
[Cover Story] »õ·Î¿î Ä¡·áÀü·«ÀÇ µîÀå°ú ±âÁ¸ Ä¡·áÀü·«ÀÇ ¾ÈÀü¼º ¹®Á¦ ´ëµÎ ÀÓ¼¼Çü ±âÀÚ 2020-03-06 17:15
¶óÀÎ
[Journal Briefing] NVAF ³úÁ¹Áß Àü Ç×ÀÀ°íÁ¦, ¿ÀÈ÷·Á À§Çè ³ôÀδ٠ÇãÈñÀ± ±âÀÚ 2020-03-04 09:59
[Journal Briefing] º¨ÆäµµÀͻꡤ°æ±¸¿ë ¼¼¸¶±Û·çŸÀ̵å À¯·´ ½ÂÀÎ 'û½ÅÈ£' ÇãÈñÀ± ±âÀÚ 2020-02-06 10:22
[Sub Story] ¸ÞÆ®Æ÷¸£¹Î ±âº»¿¡ SGLT-2i¡¤GLP-1RA Æ÷ÇÔµÅ¾ß THE MOST 2020-01-30 16:12
[Sub Story] ½É±Ù°æ»öÁõ ȯÀÚ¿¡¼­ Ç÷Àü ¿¹¹æ Àå±â Àü·« THE MOST 2020-01-30 15:58
[Sub Story] ½ÉÇ÷°ü ÇýÅà Ç÷´ç°­ÇÏÁ¦ Â÷º°È­ ±Ç°í ÀÌ»óµ· ±âÀÚ 2020-01-30 15:37
¶óÀÎ
[Sub Story] ½ÉÇ÷°üÁúȯ ¿¹¹æ À§ÇÑ Ç÷´ç°­ÇÏÁ¦ ¼±Åà ÀÌ»óµ· ±âÀÚ 2020-01-30 15:35
[Sub Story] LDLÄÝ·¹½ºÅ×·Ñ ¾ó¸¶³ª ³·°Ô ¾î¶»°Ô Á¶ÀýÇϳª? ÀÌ»óµ· ±âÀÚ 2020-01-30 15:12
[Sub Story] LDL-C £¼ 70mg/dL AMI ȯÀÚ ½ºÅ¸Æ¾ Ä¡·áÇÏ´Ï¡¦ ÀÌ»óµ· ±âÀÚ 2020-01-30 14:17
[Sub Story] KAMIR°¡ º¸¿©ÁØ Áß¼ºÁö¹æ Á¶Àý Çʿ伺 ÀÌ»óµ· ±âÀÚ 2020-01-30 14:12
[Interview] ¾Æ½Ã¾Æ ½É±Ù°æ»öÁõ °ü¸®Àü·«, 'ÄÁ¼¾¼­½º'·Î ÇÑ ¹ß ´õ ÀÓ¼¼Çü ±âÀÚ 2020-01-30 11:12
¶óÀÎ
[Conference Report] ¾ÈÁ¤Çü ½ÉÁúȯ¿¡¼­ ħ½À vs ¾à¹° ½ÂÀÚ´Â? ÀÓ¼¼Çü ±âÀÚ 2020-01-30 11:01
[Interview] Çѱ¹ÀÎ CVD °ü¸®, LDL-C°¡ ÀüºÎ ¾Æ´Ï´Ù ÀÓ¼¼Çü ±âÀÚ 2020-01-30 10:58
[Conference Report] ³·¾ÆÁø ¸ñǥġ ÀÓ»ó¿¡¼­ ±¸ÇöÇÏ·Á¸é¡¦ ÀÌ»óµ· ±âÀÚ 2019-12-03 15:20
[Conference Report] ´Ù¾çÇÑ DPP-4¾ïÁ¦Á¦ °è¿­³» Â÷º°È­ °¡´É ÀÌ»óµ· ±âÀÚ 2019-12-03 15:16
[Interview] ¡°ESC, °í¡¤ÃÊ°íÀ§Çè ´ç´¢º´ ȯÀÚµµ LDL-C 50% ÀÌ»ó ³·Ãç¾ß¡± ÀÓ¼¼Çü ±âÀÚ 2019-12-03 15:06
Back to Top